Skip to Content

Erymax 250mg (Erythromycin Delayed-Release 250 mg)

Pill with imprint Erymax 250mg is Orange / Clear, Capsule-shape and has been identified as Erythromycin Delayed-Release 250 mg. It is supplied by Midlothian Laboratories.

Erythromycin is used in the treatment of bronchitis; bowel preparation; bacterial endocarditis prevention; bartonellosis; otitis media and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Erythromycin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Erymax 250mg

Erythromycin delayed-release 250 mg Erymax 250mg

Erythromycin Delayed-Release

Imprint
Erymax 250mg
Strength
250 mg
Color
Orange / Clear
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Macrolides
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Midlothian Laboratories
National Drug Code (NDC)
68308-0250
Inactive Ingredients
FD&C Yellow No. 6, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.